Testing effectiveness (Phase 2)Study completedNCT03779841
What this trial is testing
Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)
Who this might be right for
Post-Operative Atrial Fibrillation
AbbVie 323